Transdermal technologies

Company news

19 Jun 2019

News4
Collaboration with OBJ to commercialise transdermal cannabis technologies

Little Green Pharma is pleased to announce a collaboration agreement with OBJ. Little Green Pharma and OBJ will contribute equally to the Curtin Research and Development services in Western Australia with the adaptation of the transdermal technology to deliver cannabinoid therapy transdermally, with a view to the joint ownership and commercialisation of the technology.

If the cannabinoid trials at Curtin University are successful in demonstrating that cannabinoids can effectively use OBJ’s micro-array technology:

  • this could result in one of the most advanced and effective medicinal cannabis delivery systems developed in the world, to date; and
  • the OBJ joint venture with Little Green Pharma could rapidly develop both its own products as well as licensing the technology to third parties for rapid distribution worldwide. Little Green Pharma operates from one of the few fully-licensed GMP certified medicinal cannabis manufacturing facilities in Australia.

Little Green Pharma is currently the only Australian medicinal cannabis company producing locally-grown and -manufactured GMP cannabis products for patients. Little Green Pharma cultivates locally grown medicinal cannabis from a secure facility in Western Australia and distributes its products nationally.

For the full media release and to read more about this exciting new partnership please visit: http://www.obj.com.au/wp-content/uploads/2019/06/02115462.pdf

You might also be interested in

Export2

Company news

Export licence approved

The company has been granted an Export Licence by the Federal Department of Health

Jan 2019

News2

Company news

Another successful harvest

Little Green Pharma successfully harvest another medical cannabis crop and pass TGO 93.

Jun 2019

Littlegreenpharma image

Insights

Little Green Pharma blazes onto the ASX

Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.

Feb 2020

View all articles